|
Volumn 45, Issue 6, 2010, Pages 626-627
|
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: An 8-year follow-up
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
ANTIBIOTIC AGENT;
CLARITHROMYCIN;
TRANSMEMBRANE CONDUCTANCE REGULATOR;
ADULT;
ANTIBIOTIC THERAPY;
BACTERIAL COLONIZATION;
BACTERIAL INFECTION;
BACTERIUM CULTURE;
CASE REPORT;
CYSTIC FIBROSIS;
DISEASE COURSE;
DRUG INTERMITTENT THERAPY;
ERADICATION THERAPY;
FEMALE;
FOLLOW UP;
GENE MUTATION;
HUMAN;
LETTER;
LUNG DISEASE;
MYCOBACTERIOSIS;
MYCOBACTERIUM ABSCESSUS;
MYCOBACTERIUM AVIUM;
MYCOBACTERIUM CHELONEI;
NONHUMAN;
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
QUALITY OF LIFE;
RECURRENT FEVER;
SPUTUM CULTURE;
STENOTROPHOMONAS MALTOPHILIA;
TREATMENT DURATION;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
AMIKACIN;
ANTI-BACTERIAL AGENTS;
CLARITHROMYCIN;
CYSTIC FIBROSIS;
DRUG THERAPY, COMBINATION;
FEMALE;
FORCED EXPIRATORY VOLUME;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
MYCOBACTERIUM;
MYCOBACTERIUM INFECTIONS;
NEBULIZERS AND VAPORIZERS;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
STENOTROPHOMONAS MALTOPHILIA;
|
EID: 77953312032
PISSN: 87556863
EISSN: 10990496
Source Type: Journal
DOI: 10.1002/ppul.21222 Document Type: Letter |
Times cited : (9)
|
References (4)
|